| The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection A Copaescu, O Smibert, A Gibson, EJ Phillips, JA Trubiano Journal of Allergy and Clinical Immunology 146 (3), 518-534. e1, 2020 | 246 | 2020 |
| An updated review of the diagnostic methods in delayed drug hypersensitivity A Copaescu, A Gibson, Y Li, JA Trubiano, EJ Phillips Frontiers in pharmacology 11, 573573, 2021 | 52 | 2021 |
| Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: a case series M Picard, JP Drolet, MS Masse, CA Filion, F ALMuhizi, M Fein, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (2), 620-625. e1, 2022 | 48 | 2022 |
| Efficacy of a clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: the PALACE randomized clinical trial AM Copaescu, S Vogrin, F James, KYL Chua, MT Rose, J De Luca, ... JAMA internal medicine 183 (9), 944-952, 2023 | 44 | 2023 |
| The role of in vivo and ex vivo diagnostic tools in severe delayed immune-mediated adverse antibiotic drug reactions A Copaescu, E Mouhtouris, S Vogrin, F James, KYL Chua, NE Holmes, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (5), 2010-2015. e4, 2021 | 33 | 2021 |
| SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity W Zhang, BY Chua, KJ Selva, L Kedzierski, TM Ashhurst, ER Haycroft, ... Nature communications 13 (1), 2774, 2022 | 24 | 2022 |
| Successful desensitization to mRNA COVID-19 vaccine in a case series of patients with a history of anaphylaxis to the first vaccine dose F AlMuhizi, S Ton-Leclerc, M Fein, C Tsoukas, LH Garvey, D Lee, ... Frontiers in Allergy 3, 825164, 2022 | 21 | 2022 |
| A classic clinical case: neutrophilic eccrine hidradenitis AM Copaescu, JF Castilloux, M Chababi-Atallah, C Sinave, J Bertrand Case Reports in Dermatology 5 (3), 340-346, 2013 | 21 | 2013 |
| What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later AM Copaescu, JSR Duque, EJ Phillips Annals of Allergy, Asthma & Immunology 129 (1), 40-51, 2022 | 19 | 2022 |
| The role of immunological and clinical biomarkers to predict clinical COVID-19 severity and response to therapy—a prospective longitudinal study A Copaescu, F James, E Mouhtouris, S Vogrin, OC Smibert, CL Gordon, ... Frontiers in immunology 12, 646095, 2021 | 17 | 2021 |
| Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population … AM Copaescu, F James, S Vogrin, M Rose, K Chua, NE Holmes, ... BMJ open 12 (8), e063784, 2022 | 14 | 2022 |
| Premedication protocols to prevent hypersensitivity reactions to chemotherapy: a literature review F ALMuhizi, L De Las Vecillas Sanchez, L Gilbert, AM Copaescu, ... Clinical Reviews in Allergy & Immunology 62 (3), 534-547, 2022 | 14 | 2022 |
| Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: a multicenter cohort study JA Trubiano, S Vogrin, A Copaescu, M Nasra, A Douglas, NE Holmes, ... Allergy 77 (3), 1038-1042, 2022 | 12 | 2022 |
| Dose dependent antimicrobial cellular cytotoxicity—implications for ex vivo diagnostics A Copaescu, P Choshi, S Pedretti, E Mouhtouris, J Peter, JA Trubiano Frontiers in pharmacology 12, 640012, 2021 | 12 | 2021 |
| Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: case presentation and literature review AM Copaescu, D Bouffard, MS Masse Allergy, Asthma & Clinical Immunology 16, 1-8, 2020 | 12 | 2020 |
| Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: the McGill University Health Centre experience F ALMuhizi, M Fein, S Gabrielli, L Gilbert, C Tsoukas, M Ben-Shoshan, ... Annals of Allergy, Asthma & Immunology 129 (2), 182-188. e1, 2022 | 10 | 2022 |
| Pediatric drug allergy C Prosty, AM Copaescu, S Gabrielli, P Mule, M Ben-Shoshan Immunology and Allergy Clinics 42 (2), 433-452, 2022 | 10 | 2022 |
| Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions AM Copaescu, M Ben-Shoshan, JA Trubiano Frontiers in Medicine 9, 923991, 2022 | 9 | 2022 |
| The assessment of severe cutaneous adverse drug reactions AM Copaescu, JA Trublano Australian Prescriber 45 (2), 43, 2022 | 9 | 2022 |
| The who, what, when, and where of inpatient direct oral penicillin challenge—implications for health services implementation JA Trubiano, S Vogrin, E Mitri, R Hall, A Copaescu, J Waldron, J De Luca, ... Clinical Infectious Diseases 77 (1), 19-22, 2023 | 7 | 2023 |
Professor Jason A. TrubianoAustin Health & University of Melbourne在 austin.org.au 的电子邮件经过验证
